At ASHG, an early access customer from the London Health Sciences Center Research Institute demonstrated the power of the 5-base…
New Blood-Based Assay Delivers Unparalleled Sensitivity and Specificity to enable the next generation of assay development. FREMONT, Calif., Oct. 9,…
SALT LAKE CITY and BOSTON, Sept. 23, 2025 /PRNewswire/ -- Myriad Genetics (Nasdaq: MYGN), a leader in molecular diagnostic testing and precision…
BOSTON, Sept. 22, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company transforming precision medicine, today announced an expansion…
The landmark multiomics study will examine how lifestyle, environmental, socioeconomic, and genetic factors play a significant role in shaping common…
To Advance Scientific Research in Aging, Longevity and Precision Healthcare BENGALURU, India, Sept. 9, 2025 /PRNewswire/ -- Avestagenome Project® International…
The AI-enhanced solution deepens search capabilities and improves user experience COLUMBUS, Ohio, Sept. 9, 2025 /PRNewswire/ -- CAS, a division…
ST. JOHN'S, Antigua and Barbuda, Sept. 11, 2025 /PRNewswire/ -- IQ Option, an international online broker, has announced its new…
NEW YORK, Sept. 07, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) will participate tomorrow (Monday)…
SALT LAKE CITY, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing…